Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015
Obesity2019Vol. 27(12), pp. 1975–1981
Citations Over TimeTop 1% of 2019 papers
David Saxon, Sean J. Iwamoto, Christie Mettenbrink, Emily McCormick, David Arterburn, Matthew F. Daley, Caryn Oshiro, Corinna Koebnick, Michael A. Horberg, Deborah Rohm Young, Daniel H. Bessesen
Abstract
Weight-loss medications are rarely prescribed to eligible patients. Phentermine accounted for > 75% of all medication days, with a majority of patients filling it for more than 4 months. Less than one-quarter of prescribing providers accounted for approximately 90% of all prescriptions.
Related Papers
- → Phentermine and Topiramate Extended Release (Qsymia™)(2012)35 cited
- → A Study of Abrupt Phentermine Cessation in Patients in a Weight Management Program(2010)32 cited
- → Greater hunger and less restraint predict weight loss success with phentermine treatment(2015)29 cited
- → Early Experience In Multi-Modality Treatment for Obesity(2015)
- → Early Experience with Low-Dose Phentermine for Preoperative Bariatric Weight Loss: A Prospective Randomized Trial(2017)